H.C. Wainwright raises Scholar Rock stock price target on FDA approval
At a glance
- $SRRK today+1.21%last $45.08
- Since Sep 15−9.84%from the first trade after the story
- 52-week range22.6% above low$36.78 – $61.76
- Coverage0 this week4 in 30 days · too few stories to call a pace
Nothing reported about scholar rock across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.
Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.
What it means
- What to watch: $SRRK got a new price target; the reasoning behind it says more than the number does.
- How the stock is trading: $SRRK +1.21% in the latest session.
- Timing: It was published before the opening bell, so the next session was the first chance to trade on it.
Where the stock stands
Scholar Rock Holding Corporatio ($SRRK) rose 1.21% to $45.08 in the latest session. Over the past month it is up 12.0%. It now sits 27% under the 52-week high of $61.76 and 23% above the year's low of $36.78. The high sits 68% above the low, a wide range for one year.
How much coverage it is getting
This story is more than a month old. Since then Wook has filed 4 newer stories on Scholar Rock Holding Corporatio in the last 30 days, 0 of them this week. By their wording, 1 read bullish, 3 neutral and 0 bearish.
The bigger picture
Healthcare stories turn on approvals, trial data and pricing: one FDA decision or trial readout can swing a single drugmaker hard, while drug-pricing policy moves the whole group at once.
What to watch next
For the company's side of it, read its latest SEC filings on the $SRRK page. A US company has to report material news on an 8-K, usually within four business days; foreign issuers use a 6-K. Reading how two or three outlets frame the same story is the quickest way to separate the facts from the angle. To run the numbers yourself, ask Wook AI above about $SRRK: its distance from the high, its last report, or how coverage has changed.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on September 15, 2026. $SRRK has moved -9.84% ($50.00 to $45.08). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.
